Name | (3Z)-5-Methoxy-3-[(3-{(E)-2-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]vinyl}-1H-indazol-6-yl)methylene]-1,3-dihydro-2H-indol-2-one dihydrochloride |
---|---|
Synonyms |
2H-Indol-2-one, 1,3-dihydro-5-methoxy-3-[[3-[(E)-2-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]ethenyl]-1H-indazol-6-yl]methylene]-, (3Z)-, hydrochloride (1:2)
(3Z)-5-Methoxy-3-[(3-{(E)-2-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]vinyl}-1H-indazol-6-yl)methylene]-1,3-dihydro-2H-indol-2-one dihydrochloride |
Description | CFI-400437 is potent against PLK4 (IC50 = 0.6 nM) and selective against other members of the PLK family (>10 uM). |
---|---|
In Vitro | CFI-400437 is potent against PLK4 (IC50 = 0.6 nM) and selective against other members of the PLK family (>10 uM). Against a broad panel of kinases, only a small subset is significantly inhibited. CFI-400437 is a potent inhibitor of MCF-7, MDA-MB-468, and MDA-MB-231 cell growth and very effective in a mouse xenograft model of tumor growth. |
Molecular Formula | C29H28N6O2.2HCl |
---|---|
Molecular Weight | 565.494 |
Exact Mass | 564.180725 |